Merck (NYSE:MRK) has taken a significant equity stake in Eikon Therapeutics, expanding its presence in oncology-focused biotech. The company has entered a global oncology collaboration with Guardant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results